109 related articles for article (PubMed ID: 2049755)
1. Infusional carboplatin. Phase I studies of 5-day and 14-day infusions.
Lokich J; Anderson N; Bern M; Zipli T; Gonsalves L; Moore C
Cancer; 1991 Jul; 68(1):68-71. PubMed ID: 2049755
[TBL] [Abstract][Full Text] [Related]
2. Etoposide plus carboplatin admixture. Phase I study of five- or seven-day continuous infusion.
Lokich J; Anderson N; Bern M; Zipoli T; Gonsalves L; Moore C
Am J Clin Oncol; 1992 Aug; 15(4):314-8. PubMed ID: 1514527
[TBL] [Abstract][Full Text] [Related]
3. Continuous infusion carboplatin on a 21-day schedule: a phase I and pharmacokinetic study.
Smit EF; Willemse PH; Sleijfer DT; Uges DR; Postmus PE; Meijer S; Terheggen PM; Mulder NH; de Vries EG
J Clin Oncol; 1991 Jan; 9(1):100-10. PubMed ID: 1985158
[TBL] [Abstract][Full Text] [Related]
4. Prolonged continuous infusion of carboplatin and concomitant radiotherapy in advanced head and neck cancer. A phase I study.
Ausili-Cèfaro G; Marmiroli L; Nardone L; Salvi G
Am J Clin Oncol; 1995 Jun; 18(3):273-6. PubMed ID: 7747718
[TBL] [Abstract][Full Text] [Related]
5. A phase I study of 5-day continuous venous infusion of carboplatin at circadian rhythm-modulated rate compared with constant rate.
Natoli C; Salini V; Irtelli L; Martino MT; Garufi C; Grassadonia A; Fiorentino B; Iacobelli S
Anticancer Res; 1996; 16(3A):1275-9. PubMed ID: 8702250
[TBL] [Abstract][Full Text] [Related]
6. Simultaneous dose escalation and schedule intensification of carboplatin-based chemotherapy using peripheral blood progenitor cells and filgrastim: a phase I trial.
Fennelly D; Wasserheit C; Schneider J; Hakes T; Reich L; Curtin J; Yao TJ; Markman M; Norton L; Crown J
Cancer Res; 1994 Dec; 54(23):6137-42. PubMed ID: 7525055
[TBL] [Abstract][Full Text] [Related]
7. Phase 1 study of carboplatin in patients with advanced cancer, intermittent intravenous bolus, and 24-hour infusion.
Leyvraz S; Ohnuma T; Lassus M; Holland JF
J Clin Oncol; 1985 Oct; 3(10):1385-92. PubMed ID: 3900302
[TBL] [Abstract][Full Text] [Related]
8. Phase I trial of carboplatin and infusional cyclosporin in advanced malignancy.
Morgan RJ; Margolin K; Raschko J; Akman S; Leong L; Somlo G; Scanlon K; Ahn C; Carroll M; Doroshow JH
J Clin Oncol; 1995 Sep; 13(9):2238-46. PubMed ID: 7666081
[TBL] [Abstract][Full Text] [Related]
9. Pilot study of ambulatory infusional ifosfamide admixed with carboplatin.
Lokich JJ; Zipoli TE; Anderson NR; Moore C; Gonzalves L; Bern MM; Coco F
Cancer; 1993 Mar; 71(6):2072-5. PubMed ID: 8443756
[TBL] [Abstract][Full Text] [Related]
10. Prediction of hematologic toxicity of carboplatin by creatinine clearance rate.
Taguchi J; Saijo N; Miura K; Shinkai T; Eguchi K; Sasaki Y; Tamura T; Sakurai M; Minato K; Fujiwara Y
Jpn J Cancer Res; 1987 Sep; 78(9):977-82. PubMed ID: 3117753
[TBL] [Abstract][Full Text] [Related]
11. Topotecan in combination with carboplatin: phase I trial evaluation of two treatment schedules.
Simpson AB; Calvert PM; Sludden JA; Boddy AV; Griffin MJ; Schätzlein A; Wilson P; Fishwick K; Wheatley A; Ross GA; Calvert AH; Twelves CJ
Ann Oncol; 2002 Mar; 13(3):399-402. PubMed ID: 11996470
[TBL] [Abstract][Full Text] [Related]
12. Paclitaxel by 24- or 1-hour infusion n combination with carboplatin in advanced non-small cell lung cancer: the Fox Chase Cancer Center experience.
Langer CJ; Leighton JC; Comis RL; O'Dwyer PJ; McAleer CA; Bonjo CA; Engstrom PF; Litwin S; Johnson S; Ozols RF
Semin Oncol; 1995 Aug; 22(4 Suppl 9):18-29. PubMed ID: 7544025
[TBL] [Abstract][Full Text] [Related]
13. Dose intensity for bolus versus infusion chemotherapy administration: review of the literature for 27 anti-neoplastic agents.
Lokich J; Anderson N
Ann Oncol; 1997 Jan; 8(1):15-25. PubMed ID: 9093703
[TBL] [Abstract][Full Text] [Related]
14. Prolonged administration of low dose infusional etoposide in patients with advanced malignancies. A phase I/II study.
Thompson DS; Hainsworth JD; Hande KR; Holzmer M; Greco FA
Cancer; 1994 Jun; 73(11):2824-31. PubMed ID: 8194024
[TBL] [Abstract][Full Text] [Related]
15. Multi-day fractionated administration schedule for paclitaxel.
Lokich J; Anderson N; Bern M; Coco F; Dow E; Moore C; Zipoli T; Gonzalves L
Ann Oncol; 1995 Nov; 6(9):883-5. PubMed ID: 8624290
[TBL] [Abstract][Full Text] [Related]
16. A phase I-II trial of carboplatin and 5-fluorouracil combination chemotherapy in advanced carcinoma of the head and neck.
Forastiere AA; Natale RB; Takasugi BJ; Goren MP; Vogel WC; Kudla-Hatch V
J Clin Oncol; 1987 Feb; 5(2):190-6. PubMed ID: 3543242
[TBL] [Abstract][Full Text] [Related]
17. Sequential cycles of high-dose carboplatin administered with recombinant human granulocyte-macrophage colony-stimulating factor and repeated infusions of autologous peripheral-blood progenitor cells: a novel and effective method for delivering multiple courses of dose-intensive therapy.
Shea TC; Mason JR; Storniolo AM; Newton B; Breslin M; Mullen M; Ward DM; Miller L; Christian M; Taetle R
J Clin Oncol; 1992 Mar; 10(3):464-73. PubMed ID: 1740685
[TBL] [Abstract][Full Text] [Related]
18. Pilot study of ambulatory infusional delivery of a multidrug regimen: cisplatin, 5-fluorouracil and leucovorin (PFL) +/- etoposide.
Lokich J; Anderson N; Moore C; Bern M; Coco F; Dow E; Zipoli T; Gonzalves L
J Infus Chemother; 1996; 6(1):43-6. PubMed ID: 8748007
[TBL] [Abstract][Full Text] [Related]
19. Granulocyte-macrophage colony-stimulating factor. Preliminary observations on the influences of dose, schedule, and route of administration in patients receiving cyclophosphamide and carboplatin.
Edmonson JH; Hartmann LC; Long HJ; Colon-Otero G; Fitch TR; Jefferies JA; Braich TA; Maples WJ
Cancer; 1992 Nov; 70(10):2529-39. PubMed ID: 1423182
[TBL] [Abstract][Full Text] [Related]
20. Repetitive cycles of cyclophosphamide, thiotepa, and carboplatin intensification with peripheral-blood progenitor cells and filgrastim in advanced breast cancer patients.
Shapiro CL; Ayash L; Webb IJ; Gelman R; Keating J; Williams L; Demetri G; Clark P; Elias A; Duggan D; Hayes D; Hurd D; Henderson IC
J Clin Oncol; 1997 Feb; 15(2):674-83. PubMed ID: 9053493
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
